MM
Mayank Mamtani B. Riley Securities Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Altimmune
ALT
$334M
| $3.78 | $18 |
376%
upside
| Buy | 25 days ago |
|
2
Nektar Therapeutics
NKTR
$764M
| $40.18 | $85 |
112%
upside
| Buy | 2 months ago |
|
3
Madrigal Pharmaceuticals
MDGL
$9.65B
| $432.89 | $460 |
6%
upside
| Buy | 4 months ago |
|
4
Harrow
HROW
$1.37B
| $36.99 | $65 |
76%
upside
| Buy | 5 months ago |
|
5
Trevi Therapeutics
TRVI
$854M
| $7.01 | $20 |
185%
upside
| Buy | 5 months ago |
|
6
Lineage Cell Therapeutics
LCTX
$279M
| $1.22 | $3 |
146%
upside
| Buy | 5 months ago |
|
7
Denali Therapeutics
DNLI
$2.26B
| $15.43 | $35 |
127%
upside
| Buy | 6 months ago |
|
8
Arrowhead Research
ARWR
$4.02B
| $29.07 | $38 |
31%
upside
| Buy | 6 months ago |
|
9
Viking Therapeutics
VKTX
$3.03B
| $26.98 | $96 |
256%
upside
| Buy | 7 months ago |
|
10
Novavax
NVAX
$1.28B
| $7.90 | $26 |
229%
upside
| Buy | 11 months ago |
|
|
CNTA
11
Centessa Pharmaceuticals
CNTA
$2.11B
| $15.73 | $33 |
110%
upside
| Buy | 11 months ago |
|
12
TG Therapeutics
TGTX
$5.11B
| $32.21 | $34 |
6%
upside
| Buy | 1 year ago |
|
13
Cytokinetics
CYTK
$6.34B
| $53.01 | $92 |
74%
upside
| Buy | 1 year ago |
|
14
Arcturus Therapeutics
ARCT
$485M
| $17.85 | $77 |
331%
upside
| Neutral | 4 years ago |
|
15
Galectin Therapeutics
GALT
$295M
| $4.60 | $4 |
13%
downside
| Buy | 5 years ago |
|
16
Liberty Media Series C
FWONK
$25.2B
| $100.75 | $39 |
61%
downside
| Buy | 5 years ago |
|